BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 16955192)

  • 21. A practical technique for differentiation of subepidermal bullous diseases: localization of in vivo-bound IgG by laser scanning confocal microscopy.
    Wozniak K; Kazama T; Kowalewski C
    Arch Dermatol; 2003 Aug; 139(8):1007-11. PubMed ID: 12925388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anti-p200 pemphigoid: a spectacular response to dapsone].
    Munsch C; Prey S; Joly P; Meyer N; Lamant L; Livideanu C; Viraben R; Paul C
    Ann Dermatol Venereol; 2011 Nov; 138(11):739-42. PubMed ID: 22078034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A vesicular variant of bullous pemphigoid with autoantibodies against unidentified 205- and 150-kDa proteins at the basement membrane zone.
    Satoh S; Seishima M; Izumi T; Ito A; Kamiya H; Kitajima Y
    Br J Dermatol; 1997 Nov; 137(5):768-73. PubMed ID: 9415239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Penicillin-induced anti-p200 pemphigoid: an unusual morphology.
    Wozniak K; Kowalewski C; Hashimoto T; Ishii N; Glinska-Wielochowska M; Schwartz RA
    Acta Derm Venereol; 2006; 86(5):443-6. PubMed ID: 16955192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two cases of subepidermal blistering disease with anti-p200 or 180-kD bullous pemphigoid antigen associated with psoriasis.
    Yasuda H; Tomita Y; Shibaki A; Hashimoto T
    Dermatology; 2004; 209(2):149-55. PubMed ID: 15316172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anti-p200 pemphigoid].
    Holtsche MM; Goletz S; Zillikens D
    Hautarzt; 2019 Apr; 70(4):271-276. PubMed ID: 30868255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pemphigoid nodularis: a report of three cases and review of the literature.
    Cliff S; Holden CA
    Br J Dermatol; 1997 Mar; 136(3):398-401. PubMed ID: 9115925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anti-p200 pemphigoid--a new bullous autoimmune dermatosis].
    Shimanovich I; Rose C; Hirako Y; Butt-Dörje E; Zillikens D
    J Dtsch Dermatol Ges; 2004 Jan; 2(1):7-14. PubMed ID: 16281877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transition from pemphigus foliaceus to bullous pemphigoid: intermolecular B-cell epitope spreading without IgG subclass shifting.
    Recke A; Rose C; Schmidt E; Bröcker EB; Zillikens D; Sitaru C
    J Am Acad Dermatol; 2009 Aug; 61(2):333-6. PubMed ID: 19615544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vancomycin-induced linear IgA bullous disease presenting as toxic epidermal necrolysis.
    Waldman MA; Black DR; Callen JP
    Clin Exp Dermatol; 2004 Nov; 29(6):633-6. PubMed ID: 15550142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A bullous pemphigoid-like skin eruption after a chemical burn.
    Chen DM; Fairley JA
    J Am Acad Dermatol; 1998 Feb; 38(2 Pt 2):337-40. PubMed ID: 9486711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of dapsone in the treatment of pemphigus and pemphigoid: analysis of current data.
    Gürcan HM; Ahmed AR
    Am J Clin Dermatol; 2009; 10(6):383-96. PubMed ID: 19824739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bullous pemphigoid and multiple sclerosis: a report of two cases with ELISA test.
    Peramiquel L; Barnadas MA; Pimentel CL; García Muret MP; Puig LL; Gelpí C; Agustí M; Alomar A
    Eur J Dermatol; 2007; 17(1):62-6. PubMed ID: 17324830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case of concurrent epidermolysis bullosa acquisita and anti-p200 pemphigoid--how to treat it?
    Pastar Z; Rados J; Lipozencic J; Dobric I; Marinovic B; Ishii N; Hashimoto T
    Int J Dermatol; 2007 Mar; 46(3):295-8. PubMed ID: 17343589
    [No Abstract]   [Full Text] [Related]  

  • 35. Paraneoplastic bullous pemphigoid resembling erythema gyratum repens.
    Hauschild A; Swensson O; Christophers E
    Br J Dermatol; 1999 Mar; 140(3):550-2. PubMed ID: 10233292
    [No Abstract]   [Full Text] [Related]  

  • 36. Epidermolysis bullosa acquisita associated with psoriasis vulgaris.
    Hoshina D; Sawamura D; Nomura T; Tanimura S; Abe M; Onozuka T; Kodama K; Akiyama M; Shimizu H
    Clin Exp Dermatol; 2007 Sep; 32(5):516-8. PubMed ID: 17459071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Furosemide-induced bullous pemphigoid: case report and review of literature.
    Lee JJ; Downham TF
    J Drugs Dermatol; 2006 Jun; 5(6):562-4. PubMed ID: 16774111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cicatrising conjunctivitis with anti-basement membrane autoantibodies in ectodermal dysplasia.
    Saw VP; Dart JK; Sitaru C; Zillikens D
    Br J Ophthalmol; 2008 Oct; 92(10):1403-10. PubMed ID: 18815422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pemphigoid gestationis: a pregnancy-related pathology underestimated by obstetricians].
    Jamel K; Wahiba K; Youssef BB; Hassen J; Monia K; Narjess C; Abdelaziz F
    Tunis Med; 2005 Jul; 83(7):437-40. PubMed ID: 16220705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-induced bullous pemphigoid.
    Fellner MJ
    Clin Dermatol; 1993; 11(4):515-20. PubMed ID: 8124641
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.